Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Profit After Tax: 2019-2025

Historic Profit After Tax for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' Profit After Tax rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.7 million, marking a year-over-year increase of 51.42%. This contributed to the annual value of $145.5 million for FY2024, which is 12.91% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Profit After Tax of $50.9 million as of Q3 2025, which was up 27.88% from $39.8 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Profit After Tax's 5-year high stood at $87.9 million during Q3 2022, with a 5-year trough of -$9.6 million in Q3 2021.
  • Its 3-year average for Profit After Tax is $37.3 million, with a median of $38.5 million in 2023.
  • Over the last 5 years, Harmony Biosciences Holdings' Profit After Tax had its largest YoY gain of 52,385.19% in 2021, and its largest YoY loss of 603.93% in 2021.
  • Over the past 5 years, Harmony Biosciences Holdings' Profit After Tax (Quarterly) stood at $22.7 million in 2021, then spiked by 113.56% to $48.5 million in 2022, then crashed by 45.15% to $26.6 million in 2023, then soared by 85.95% to $49.5 million in 2024, then rose by 10.35% to $50.9 million in 2025.
  • Its Profit After Tax was $50.9 million in Q3 2025, compared to $39.8 million in Q2 2025 and $45.6 million in Q1 2025.